Biotechnology — Segment Reporting, Other Segment Item, Amount
Danaher Biotechnology — Segment Reporting, Other Segment Item, Amount increased by 10.8% to $1.21B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 8.9%, from $1.11B to $1.21B. Over 3 years (FY 2022 to FY 2025), Biotechnology — Segment Reporting, Other Segment Item, Amount shows relatively stable performance with a -3.4% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
How to read this metric
High or rising levels may indicate operational inefficiencies or frequent restructuring activities.
Detailed definition
Captures miscellaneous operating items or adjustments specific to the biotechnology segment that do not fit into standar...
Peer comparison
Varies significantly by company; often found in segment reconciliation notes.
dhr_segment_biotechnology_segment_reporting_other_segment_item_amountHistorical Data
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.19B | $1.19B | $1.19B | $1.19B | $1.05B | $1.05B | $1.05B | $1.05B | $939.00M | $1.00B | $1.01B | $1.11B | $924.00M | $1.05B | $1.09B | $1.21B |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -11.9% | +0.0% | +0.0% | +0.0% | -10.2% | +6.7% | +0.7% | +10.0% | -16.8% | +14.0% | +3.6% | +10.8% |
| YoY Change | — | — | — | — | -11.9% | -11.9% | -11.9% | -11.9% | -10.2% | -4.2% | -3.5% | +6.1% | -1.6% | +5.1% | +8.1% | +8.9% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Danaher's biotechnology — segment reporting, other segment item, amount?
- Danaher (DHR) reported biotechnology — segment reporting, other segment item, amount of $1.21B in Q4 2025.
- How has Danaher's biotechnology — segment reporting, other segment item, amount changed year-over-year?
- Danaher's biotechnology — segment reporting, other segment item, amount increased by 8.9% year-over-year, from $1.11B to $1.21B.
- What is the long-term trend for Danaher's biotechnology — segment reporting, other segment item, amount?
- Over 3 years (2022 to 2025), Danaher's biotechnology — segment reporting, other segment item, amount has grown at a -3.4% compound annual growth rate (CAGR), from $4.75B to $4.28B.
- What does biotechnology — segment reporting, other segment item, amount mean?
- Other miscellaneous operating costs or adjustments specific to the biotechnology segment.